Header Logo

Connection

SUSAN HILSENBECK to Cisplatin

Back to Details
This is a "connection" page, showing publications SUSAN HILSENBECK has written about Cisplatin.
SUSAN HILSENBECK
Connection Strength
0.196
Cisplatin
  1. Carbon nanotube capsules enhance the in vivo efficacy of cisplatin. Acta Biomater. 2017 08; 58:466-478.
    View in: PubMed
    Score: 0.129
  2. Five-drug antiemetic combination for cisplatin chemotherapy. Cancer Invest. 1992; 10(3):191-9.
    View in: PubMed
    Score: 0.022
  3. Hippo pathway effector Yap is an ovarian cancer oncogene. Cancer Res. 2010 Nov 01; 70(21):8517-25.
    View in: PubMed
    Score: 0.020
  4. Chemical enhancement of cisplatin cytotoxicity in a human ovarian and cervical cancer cell line. Gynecol Oncol. 1990 Sep; 38(3):315-22.
    View in: PubMed
    Score: 0.020
  5. Toxicity of FED chemotherapy in non-small-cell lung cancer. Am J Clin Oncol. 1987 Dec; 10(6):499-506.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.